Clorotepine mesylate

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 413167

CAS#: 42505-79-3 (mesylate)

Description: Clorotepine mesylate is the salt form of Clorotepine (free base), a major tranquilizer with action similar to those of the phenothiazines; used in schizophrenic & manic psychoses.

Chemical Structure

img
Clorotepine mesylate
CAS# 42505-79-3 (mesylate)
Instruction

Theoretical Analysis

MedKoo Cat#: 413167
Name: Clorotepine mesylate
CAS#: 42505-79-3 (mesylate)
Chemical Formula: C20H25ClN2O3S2
Exact Mass: 440.10
Molecular Weight: 441.000
Elemental Analysis: C, 54.47; H, 5.71; Cl, 8.04; N, 6.35; O, 10.88; S, 14.54

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 13448-22-1 (free base)   42505-79-3 (mesylate)  

Synonym: Clorotepine mesylate; Clorotepin methanesulfonate

IUPAC/Chemical Name: 1-(8-Chloro-10,11-dihydrodibenzo(b,f)thiepin-10-yl)-4-methylpiperazinium methanesulphonate

InChi Key: XQRUOHZMMIUQSB-UHFFFAOYSA-N

InChi Code: InChI=1S/C19H21ClN2S.CH4O3S/c1-21-8-10-22(11-9-21)17-12-14-4-2-3-5-18(14)23-19-7-6-15(20)13-16(17)19;1-5(2,3)4/h2-7,13,17H,8-12H2,1H3;1H3,(H,2,3,4)

SMILES Code: CN1CC[NH+](C2CC3=CC=CC=C3SC4=CC=C(Cl)C=C24)CC1.CS(=O)([O-])=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 441.00 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Roth BL, Craigo SC, Choudhary MS, Uluer A, Monsma FJ Jr, Shen Y, Meltzer HY, Sibley DR. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther. 1994 Mar;268(3):1403-10. PMID: 7908055.

2: Viswanathan G, Yadav S, Raghunand TR. Identification of Mycobacterial Genes Involved in Antibiotic Sensitivity: Implications for the Treatment of Tuberculosis with β-Lactam-Containing Regimens. Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00425-17. doi: 10.1128/AAC.00425-17. PMID: 28438925; PMCID: PMC5487644.

3: Risgaard R, Ettrup A, Balle T, Dyssegaard A, Hansen HD, Lehel S, Madsen J, Pedersen H, Püschl A, Badolo L, Bang-Andersen B, Knudsen GM, Kristensen JL. Radiolabelling and PET brain imaging of the α₁-adrenoceptor antagonist Lu AE43936. Nucl Med Biol. 2013 Jan;40(1):135-40. doi: 10.1016/j.nucmedbio.2012.09.010. Epub 2012 Nov 17. PMID: 23165140.

4: Nisa S, Blokpoel MC, Robertson BD, Tyndall JD, Lun S, Bishai WR, O'Toole R. Targeting the chromosome partitioning protein ParA in tuberculosis drug discovery. J Antimicrob Chemother. 2010 Nov;65(11):2347-58. doi: 10.1093/jac/dkq311. Epub 2010 Sep 1. PMID: 20810423; PMCID: PMC2980951.

5: Kristensen JL, Püschl A, Jensen M, Risgaard R, Christoffersen CT, Bang- Andersen B, Balle T. Exploring the neuroleptic substituent in octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for α(1)-adrenoceptors. J Med Chem. 2010 Oct 14;53(19):7021-34. doi: 10.1021/jm100652h. PMID: 20857909.

6: Tehan BG, Lloyd EJ, Wong MG. Molecular field analysis of clozapine analogs in the development of a pharmacophore model of antipsychotic drug action. J Mol Graph Model. 2001;19(5):417-26, 468. doi: 10.1016/s1093-3263(00)00101-7. PMID: 11552690.

7: Zapletálek M, Zbytovský J, Kindernayová H. Clinical and experimental study of oxyprothepine. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 1980;23(4):487-90. PMID: 6111116.

8: Metysová J, Metys J, Dlabac A, Kazdová E, Valchár M. Pharmacological properties of a potent neuroleptic drug octoclothepin. Acta Biol Med Ger. 1980;39(6):723-40. PMID: 6893891.

9: Polák L, Molcan J. Clonidine in hyperkinetic children. Act Nerv Super (Praha). 1990 Mar;32(1):66-7. PMID: 1973018.

10: Bøgesø KP, Liljefors T, Arnt J, Hyttel J, Pedersen H. Octoclothepin enantiomers. A reinvestigation of their biochemical and pharmacological activity in relation to a new receptor-interaction model for dopamine D-2 receptor antagonists. J Med Chem. 1991 Jul;34(7):2023-30. doi: 10.1021/jm00111a015. PMID: 1676758.